http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8899344

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase II|Journal Article|Multicenter Study
endingPage 1210
issn 1532-1827
0007-0920
issueIdentifier 9
pageRange 1206-1210
publicationName British Journal of Cancer
startingPage 1206
bibliographicCitation Carles J, Font A, Mellado B, Domenech M, Gallardo E, González-Larriba JL, Catalan G, Alfaro J, Gonzalez del Alba A, Nogué M, Lianes P, Tello JM. Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II study. British Journal of Cancer. 2007 Oct 23;97(9):1206–10. doi: 10.1038/sj.bjc.6604030.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c7b5a3d39584a1cc2b1539f3c27b5ff
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_813f5fa954015efd7ed169391245fbdf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b6293d94762462b64feba852da30dd14
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ff3ed2559c646762e5c14f294617903
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_814f2a2d3e5539901c0420bccc6b1b05
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c3b3eb3c6540a9cd7f678123f22a53a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_57849b1e0f0697b426649e6a254eb6c3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0010380c8d007651d40f61483569dc87
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_813bb9dbc8296b37a8921087ec8f89ac
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a43d660944ba2acb324d439074c478f5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_887262bdb39bf154ef88b41eaf051718
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5a35bf9ac98828c6a340df037c503f1
date 2007-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1038/sj.bjc.6604030
https://pubmed.ncbi.nlm.nih.gov/17955053
https://pubmed.ncbi.nlm.nih.gov/PMC2360463
isPartOf https://portal.issn.org/resource/ISSN/0007-0920
https://portal.issn.org/resource/ISSN/1532-1827
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II study
discusses http://id.nlm.nih.gov/mesh/M0276185
http://id.nlm.nih.gov/mesh/M0018226
http://id.nlm.nih.gov/mesh/M0443608
http://id.nlm.nih.gov/mesh/M0184558
http://id.nlm.nih.gov/mesh/M0007783
http://id.nlm.nih.gov/mesh/M0020790
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fce276cc0efd2412c7dafdbb1e82fcc8
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2662
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7507
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6983
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.21.77
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID259331

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129202881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129728658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127638306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129696267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128856633
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128610606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135782887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129046631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128397534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127889566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129506098

Total number of triples: 66.